Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women

NCT00107016 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

267

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasm

Interventions

DRUG: RAD001, Letrozole 2.5mg
DRUG: Letrozole 2.5mg

Sponsor

Novartis Pharmaceuticals